Minn. AG's Insulin Pricing Suit Survives, Minus RICO Claims
Sanofi-Aventis, Novo Nordisk and Eli Lilly can't toss all claims in the Minnesota attorney general's antitrust lawsuit against them over soaring insulin pricing, a New Jersey federal judge said....To view the full article, register now.
Already a subscriber? Click here to view full article